Eton Pharmaceuticals Inc (ETON)
11.63
+0.40
(+3.56%)
USD |
NASDAQ |
Nov 25, 14:04
Eton Pharmaceuticals Net Income (Quarterly): 0.627M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.627M |
June 30, 2024 | -3.041M |
March 31, 2024 | -0.811M |
December 31, 2023 | -2.256M |
September 30, 2023 | -0.579M |
June 30, 2023 | 4.559M |
March 31, 2023 | -2.66M |
December 31, 2022 | 0.912M |
September 30, 2022 | -3.045M |
June 30, 2022 | -1.558M |
March 31, 2022 | -5.33M |
December 31, 2021 | 1.039M |
September 30, 2021 | -6.094M |
June 30, 2021 | -2.016M |
Date | Value |
---|---|
March 31, 2021 | 5.116M |
December 31, 2020 | -7.687M |
September 30, 2020 | -6.504M |
June 30, 2020 | -4.73M |
March 31, 2020 | -9.049M |
December 31, 2019 | -2.696M |
September 30, 2019 | -4.965M |
June 30, 2019 | -3.249M |
March 31, 2019 | -7.41M |
December 31, 2018 | -3.73M |
September 30, 2018 | -2.91M |
June 30, 2018 | -3.082M |
March 31, 2018 | -3.018M |
September 30, 2017 | -2.802M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-9.049M
Minimum
Mar 2020
5.116M
Maximum
Mar 2021
-2.290M
Average
-2.458M
Median
Net Income (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | 106.08M |
Integra Lifesciences Holdings Corp | -10.70M |
Elutia Inc | 1.286M |
Immuneering Corp | -14.60M |
Journey Medical Corp | -2.39M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 10.32M |
Total Expenses (Quarterly) | 9.815M |
EPS Diluted (Quarterly) | 0.02 |
Enterprise Value | 274.00M |
Gross Profit Margin (Quarterly) | 61.04% |
Profit Margin (Quarterly) | 6.07% |
Earnings Yield | -1.89% |
Normalized Earnings Yield | -1.892 |